Axsome Therapeutics
AXSM
$72.28
Share price
1.56%
Change (1 day)
-1.42%
Change (1 year)
Categories
Axsome Therapeutics (AXSM) - P/B ratio
P/B ratio as of April 2024 : 17.7
According to Axsome Therapeutics
's latest financial reports the company has a price-to-book ratio of 17.7.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Axsome Therapeutics - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 19.7 | -35.5% |
| 2022-12-31 | 30.6 | -66.44% |
| 2021-12-31 | 91.1 | 240.75% |
| 2020-12-31 | 26.7 | 25.17% |
| 2019-12-31 | 21.4 | -76.39% |
| 2018-12-31 | 90.5 | 960.89% |
| 2017-12-31 | 8.53 | 42.27% |
| 2016-12-31 | 5.99 | 56.81% |
| 2015-12-31 | 3.82 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -86.24% | 🇺🇸 USA |